New drug MK-1045 tested for lupus and arthritis safety
NCT ID NCT07363590
First seen Feb 01, 2026 · Last updated Apr 28, 2026 · Updated 15 times
Summary
This early-stage study tests a new medicine called MK-1045 in people with lupus or rheumatoid arthritis. The main goal is to check if the drug is safe and tolerable at different doses. About 21 participants will take part to help researchers understand how the body processes the drug and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anima Diepenbeek ( Site 0601)
RECRUITINGDiepenbeek, Limburg, 3590, Belgium
Contact Phone: •••-•••-••••
-
Arensia Exploartory Medicine ( Site 1301)
RECRUITINGTbilisi, 0112, Georgia
Contact Phone: •••-•••-••••
-
Istituto Clinico Humanitas- IRCCS ( Site 1902)
RECRUITINGRozzano, Milano, 20089, Italy
Contact Phone: •••-•••-••••
-
PMSI Republican Clinical Hospital "T.Mosneaga" ( Site 1001)
RECRUITINGChisinau, 2025, Moldova
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.